Gene-Disorder Association · Article
Gene
F8 Coagulation Factor VIII
×
First reported
1985
Supporting publications
268
Manually curated Approved treatment annotated
Association Review
In brief The association between F8 (Coagulation Factor VIII) and Hemophilia A is well established and manually curated, with its 5 contributing sources — 4 of them expert-curated — recording a known molecular basis, pathogenic and likely-pathogenic variants, and a causative germline mutation.
Sources
5
Clinical variants
687
Symptoms
60
Compounds
5
Trials
20 of 75 via F8 compounds
Publications
268
Contents
01
At a glance
Association overview A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access 02
Provenance
Evidence and sources 5 sources
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access 1 source summary
A gene summary alongside the source descriptions it was distilled from.
Request access 18 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access 05
Phenotype
Clinical features 50 clinical features
The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.
Request access 06
ClinVar and variant evidence
Genetic basis 687 clinical variants
ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.
Request access 07
Genomic context
Regulatory context 3 regulatory elements
GeneHancer regulatory elements for the pair, with coordinates, score, element type and supporting literature.
Request access 08
Mechanism overlap
Shared mechanisms Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.
Request access 09
Interventions
Therapeutics 5 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access 10
Human studies
Clinical trials 75 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access 268 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access 12
Provenance
References & sources 20 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access 
